About

Andreas Bohrer has an excellent track record of corporate and commercial work. He demonstrated this, along with his high performing team at Novartis, with the multi-jurisdictional $50bn acquisition and merger of Alcon Inc into Novartis in 2010-2011. He also co-lead the successful integration of Novartis Animal Health (NAH) into Eli Lilly & Company in 2014-2015. Andreas has adopted an impeccable method to support and motivate his team of 200 legal and compliance professionals at every step of their career. One method is the continual support he gives to senior lawyers to become trusted business partners. Those who have worked with him have said that he can ‘bring out the best in people’. He prides himself in having created a diverse department that promotes collaboration among the teams and has established a program to exchange in-house counsel between the teams, and in particular with headquarters. His multi-spanning professional expertise covers pharmaceuticals, banking and the non-financial sector. This experience has allowed him to function as a board member in operating subsidiaries as well as third party firms in both the financial and non-financial sector. In addition, his expertise on governance has lead him to write a habilitation thesis on corporate governance and capital markets. When discussing the highlights of his career he explains how he has led a team of highly skilled individuals to achieve some of the most complex and innovative transactions within very ambitious timelines at Novartis, UBS and Lonza. On the changing role of the in-house lawyer Andreas Bohrer concedes that ‘the legal and regulatory frameworks are converging between industries and between jurisdictions, and the role of in-house counsel has developed dramatically in the past 12-15 years, certainly in Switzerland, if not everywhere. From the back-seat role of a reactive service provider into the driver seat in major transactions as well as a corporation’s governance, in-house counsel have stepped up in their roles and responsibilities, and their profile has developed accordingly’.